RANDOMISED PHASE III TRIAL COMPARING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) WITH ONE COURSE OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH STAGE I NON-SEMINOMATOUS GERM CELL TUMOUR PATIENTS (NSGCT) – UPDATED RESULTS OF AUO TRIAL 01/94
P. Albers, R. Siener, S. Krege, H.U. Schmelz, K.P. Dieckmann, A. Heidenreich, P. Kwasny, M. Pechoel, J. Lehmann, S. Kliesch, K.U. Köhrmann, R. Fimmers, L. Weißbach, V. Loy, C. Wittekind, M. HartmannVolume:
7
Year:
2008
Language:
english
DOI:
10.1016/s1569-9056(08)60057-3
File:
PDF, 69 KB
english, 2008